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Background: The incidence of primary central nervous system (CNS) melanocytic neoplasms is relatively low
comparing to systemic ones. The performance of the tumor is variable. With poor clinical experience, the diagnosis
and treatment of such tumors present to be a challenge. Amelanotic melanoma is an especially rare subtype. Only
several cases have been reported.
Case presentation: We report a case of intracranial amelanotic melanoma. Preoperative assessment revealed
progressive right frontal mass. The patient underwent tumor resection. The pathologic analysis reported amelanotic
melanoma of intermediate grade. The further examination of the whole brain and body was negative. The familial
history was also negative. The patient recovered uneventfully and went on for radiotherapy and chemotherapy.
After a follow-up period of 5 months, the patient was tumor-free.
Conclusions: This is the second report about primary CNS amelanotic melanoma. We summarized characteristics of
the primary CNS melanocytic lesions and amelanotic melanoma with review of the literature and review of cases of
our department.
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Primary melanocytic neoplasms of the central nervous
system (CNS) belong to the tumors of the meninges.
The incidence is less than 0.1%. Some may relate to cer-
tain neurocutaneous syndrome. The tumor can affect
the entire CNS, with miscellaneous performances. The
diagnosis is always difficult before the pathology result is
available. And due to the potential of malignant trans-
formation and dissemination, the identification of the
original loci is even harder. So the clinical diagnosis and
treatment must base on an overall evaluation of a patient.
Primary amelanotic melanoma is a special subtype of the
melanocytic neoplasm, which is especially rare. We want
to share our experiences of primary CNS melanocytic
neoplasms and amelanotic melanoma through our cases
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Medical history
A 64-year-old man presented to our department in De-
cember 2013 for progressive right frontal mass with dull
aching for 9 months. His medical history was unremark-
able except for 2 years of hypertension. The familial history
was negative, with no neurocutaneous system disorders of
the first grade relatives.Clinical examination
The vital signs were stable. A mass at the right frontal
region could be palpated, about 5 cm in diameter, hard,
fixed, with no obviously red, swollen, or tender of the
superficial scalp.Imaging studies
Cranial CT scan showed an mixed iso-/hyperdensity mass
in the right frontal cranial bone, about 60 to 198 Hu,
measuring 34 × 21 mm, with clear margin. The peripheral
bone appeared destructive absorption. The MR was
contraindicated for metal implant (Figure 1).s is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Preoperative CT scan of the patient. The lesion locates in the right frontal bone, isointense on CT scan, with prominent bone
destruction. (a) CT scan of the soft tissue. (b) CT scan of the cranial bone.
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The patient underwent total tumor resection through
right frontal approach on 24 December, 2013. The tumor
eroded both the external and internal lamina of the cranial
bone. The tumor was solid, soft, tender, pale white, rich
blood supplied, and was adhesive to the underlying dura
mater. The dura mater was yet intact, sparing the paren-
chyma of the cortex. The intraoperative rapid frost patho-
logic examination revealed malignant changes, and so
after tumor resection, the adjacent dura mater was re-
moved as well which was reconstructed with self aponeur-
osis. The peripheral bone was resected to the negative
zone. The excision margin was about 2 cm.
The pathologic examination reported amelanotic mel-
anoma of intermediate grade, with positive of HMB45,
MelanA (sparsely), S-100,Vimentin, CD99, SMA (sparsely),
and CD34, and negative of CK, EMA, CEA, CK5/6, CK8/
18, TTF-1, SYN, CD56, CgA, Desmin, MyoD1, TFE3,
PAS, and PR. The Ki-67 was 20% to 30% (±) (Figure 2).
The further examination includes CT scan of the chest,
abdominal, and the pelvic region and the PET scan of the
whole brain and body, which were all negative.
The patient was discharged 3 days after the operation
with no complications and went on for adjuvant radio-
therapy and chemotherapy (concomitant stereotactic ra-
diosurgery + ipilimumab). For more than 5 months of
follow-up, the patient recovers well with no recurrence
or related sequelae.
Review of cases and literature
We summarized the CNS melanocytic lesions of our
neurosurgery department since 2008. Then we used the
search engine of PubMed with keywords of melanoma
or melanomatosis or melanocytoma or melanocytosis,
and CNS and primary and further searched with key-
words of CNS or brain or cranial or spinal, and amelanotic.
Thirty-two cases of CNS melanocytic lesions of our
department were defined since 2008. Forty-three Englishreports of CNS melanocytic lesions and 14 reports about
CNS amelanotic melanoma were searched. The details
were summarized in the tables (Tables 1, 2, and 3).
Discussion
Primary melanocytic neoplasms of the CNS belong to
the tumors of the meninges, further classified as diffuse
melanocytosis, melanocytoma, malignant melanoma,
and meningeal melanomatosis. The incidence is 0.06%
to 0.1% of melanocytoma and 0.005/100,000 of melan-
oma. Other subtypes are rare. There is a slight female
predisposition, with the ratio of F:M = 1.5:1. The age
range of melanocytoma is 9 to 73 years, most frequently
from 45 to 50 years, and of the primary nodular melan-
oma is 15 to 71 years, averaging 43 years. The symptoms
and signs are secondary to either the local effects on the
CNS parenchyma or the accompanying hydrocephalus.
The rapid progress with increasing ICP resulting in
irritability, vomiting, lethargy, seizures, and so on may
suggest malignant transformation. The diagnosis of mel-
anocytic lesions relies on the histopathological examin-
ation. Most benign and malignant melanocytic lesions
display melanin pigment distributed within tumor cells,
tumor stroma, and the cytoplasm of tumoral macro-
phages (melanophages). Tumor with CNS invasion or el-
evated mitotic activity is classified as intermediate grade
melanocytic neoplasms. Malignant melanoma is more
pleomorphic, has more anaplastic nuclei, higher cell dens-
ity, and unequivocal invasion or coagulative necrosis. Rare
melanocytomas and occasional primary melanomas will
not demonstrate melanin pigment, complying with ‘amela-
notic’ Amelanotic melanoma may arise from normal mel-
anoma with amelanotic transformation or detergent of the
tumor cell. Histopathological and immunohistochemistry
examinations are highly sensitive to amelanotic melan-
oma. The neuroimaging performance depends on the
content of melanin. Isiklar et al. [1] classified the MR
performance into four groups: a) The melanotic group,
Figure 2 Pathologic results. (a) Pathology slice (hematoxylin-eosin stain, original magnification ×100) of the tumor. Nests of intermediate-grade
tumor cells with intervening stroma can be seen. The tumor cells show clear to eosinophilic cytoplasm, with no obvious pigment. (b) Higher
magnification (hematoxylin-eosin stain, original magnification ×400) of the tumor, showing prominent nuclear mitosis and atypia. (c) Higher
magnification (original magnification ×400) of the tumor, showing HMB45 positive. (d) Higher magnification (original magnification ×400) of the
tumor, showing S-100 positive. (e) Higher magnification (original magnification ×400) of the tumor, showing Vimentin-positive. (f) Higher magnification
(original magnification ×400) of the tumor, showing Ki-67 index, was 20% to 30%.
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amelanotic group, with iso-/hypointense on T1 and iso-/
hyperintense on T2. c) The mixed group, suiting neither
the two criteria. d) The hemorrhagic group, with charac-
teristics of intra-/peri-tumoral hemorrhage. Gaviani et al.
[2] reported that the T1 signal has positive correlation
with the content of melanin, while T2 signal has no such
correlation but is more sensitive to tiny loci.
Early in 1980s, Willis et al. pointed out that the diag-
nosis of ‘primary’ has to meet three critical conditions:
a) The skin or eyeballs are negative of melanoma. b) The
skin or eyeballs have no history of melanoma resection.
c) The internal organs are negative of metastasis of melan-
oma. Savitz [3] thought that the systemic melanocyticlesions are very likely to metastases to CNS while the pri-
mary loci are quite indolent. Winkelman et al. [4] reported
that 44% of all melanocytic lesions have CNS metastasis at
autopsy, so that the ‘primary’ can only be confirmed after
autopsy. So every melanocytic neoplasm may be a systemic
disease, and the ‘primary CNS melanocytic lesion’ is just a
subtype with CNS as the single manifestation clinically.
There are approximately more than 60 papers describing
primary CNSmelanocytic lesions, with about 40 are in Eng-
lish, dated from 1972 to 2013. The number of cases ranged
from one to ten. The symptoms are various according to
the location of the tumor and so are the neuroimaging per-
formance relating to the content of the melanin, as men-
tioned before. About 14 papers referred to CNS amelanotic
Table 1 Summary of CNS melanocytic lesions of our neurosurgery department since 2008
Case Gender Age
(yr.)
Location Pathology diagnosis Preoperative differentiationa
1 M 46 Left temporal Intermediate-grade melanocytic tumor -
2 M 11 Right temporal Malignant melanoma -
3 M 45 Right frontal Malignant melanoma Metastasis? Lymphoma?
4 F 26 Right parasellar Malignant melanoma Schwannoma?
5 F 52 Left frontal Metastatic melanoma -
6 M 43 Right temporal Meningeal melanomatosis Metastasis? Pleomorphic
xanthoastrocytoma?
7 M 47 Right CPA Meningeal melanomatosis Epidermoid cyst? Cavernous
hemangioma?
8 M 24 Right lateral ventricle Amelanotic melanoma? -
9 F 19 Left parietal Melanocytoma Meningioma?
10 F 21 Right frontal, para-falx Recurrent melanocytoma, with subarachnoid dissemination Recurrent melanocytoma
11 M 38 Right petrosal Meningeal melanomatosis Schwannoma?
12 M 61 Multiple Melanocytoma with meningeal melanomatosis Melanoma? Metastasis?
13 M 20 Left temporal Malignant melanoma -
14 M 24 Right cerebellar Malignant melanoma Cyst?
15 M 47 Foreman magnum Malignant melanoma, with bone invasion Meningioma? Melanoma?
16 M 47 Left middle fossa Malignant melanoma Hemangiopericytoma?
Meningioma? Melanoma?
17 M 45 Intradural extramedullary,
C2-T1
Melanocytoma Melanoma? Meningioma?
18 M 31 Right cavernous sinus Melanocytoma Melanoma? Cavernous
hemangioma? Aneurysm?
19 M 46 Right middle fossa Malignant melanoma, with bone and dura invasion Meningioma?
20 M 20 Left pons Malignant melanoma Glioma? Meningioma?
21 F 41 Multiple, T6-L1 Melanocytoma Neurofibrosis?
22 F 28 Right parietal occipital Malignant melanoma, with subarachnoid dissemination -
23 F 66 Left frontal Malignant melanoma -
24 M 27 Right interspinous
foramen, C6
Melanocytoma Melanoma?
25 M 39 Foramen magnum - C2 Melanocytoma Lipoma?
26 M 36 Right frontal Melanocytoma, with subarachnoid dissemination and
parenchyma invasion
Melanoma? Lymphoma?
27 M 49 Right cerebellar tentorium Meningeal melanomatosis Meningioma?
28 M 17 Left parasallar - CPA Melanocytoma Epidermoid cyst?
29 M 26 Medulla Intermediate grade melanocytic tumor -
30 M 13 Right cerebellar tentorium Malignant melanoma Meningioma?
Hemangiopericytoma?
31 M 47 Left temporal Malignant melanoma -
32 M 64 Right frontal bone Amelanotic melanoma, with bone invasion Eosinophilic granuloma?
Giant cell osteoma? Metastasis?
M, male; F, female, yr., years old. aWith no clear preoperative diagnosis.
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cluding two primary intraspinal and two primary menin-
geal amelanotic melanoma, 22 intracerebral metastasis,
one intraventricular metastasis, and three cases with nodetails. Schuknecht et al. [5] reported two primary menin-
geal amelanotic melanoma in 1990, serving as the only
paper describing primary CNS amelanotic melanoma.
There are totally 32 primary or metastatic CNS melanocytic
Table 2 Review of the English literature of CNS melanocytic lesions
Author Year Nb Primary/metastatica Diagnosis Other
Foit et al. 2013 1 Primary Melanocytoma -
Lee et al. 2013 1 Primary Meningeal
melanomatosis
-
Schneider et al. 2013 1 Primary Malignant melanoma -
Reddy et al. 2012 1 - Melanocytoma -
Sutton et al. 2011 1 - Leptomeningeal
melanocytosis
The patient was suspected to represent a case of
former fruste neurocutaneous melanosis.
Brunsvig et al. 1 - Meningeal
melanocytosis
-
Vij et al. 2010 1 Primary Melanoma -
Perrini et al. 2010 1 Primary Malignant melanoma -
Zadro et al. 2010 1 Primary Diffuse meningeal
melanomatosis
-
Nishihara et al. 2009 1 Primary Malignant melanoma -
Navas et al. 2009 1 - Meningeal
melanocytoma
Associated with a congenital nevus of Ota
Holfort et al. 2009 16 Metastatic Melanoma Out of review of primary uveal melanoma 2365
patients




Tandon et al. 2008 1 Primary Melanocytoma -
Levidou et al. 2007 2 Unknown primary site Leptomeningeal
melanoma
-
Cajaiba et al. 2008 2 Primary Neurocutaneous
melanosis with CNS
melanocytoma
Disseminated to the peritoneal surface by
ventriculo-peritoneal (V-P) shunt system
Mekni et al. 2007 5 Primary Malignant melanoma -
Denaro et al. 2007 1 Primary Melanoma -
Bookland et al. 2007 1 Primary Malignant melanoma -




Oluigbo et al. 2006 1 Primary Malignant melanoma -
Chen 2003 1 - Meningeal
melanocytoma
-
Classen et al. 2002 1 - Melanocytoma -
Rivers et al. 2001 1 Primary Dural melanoma In association with ocular melanosis and multiple
cutaneous blue nevi
Greco Crasto et al. 2001 1 Primary Melanoma -
Whinney et al. 2001 1 Primary Malignant melanoma -
Kobayashi et al. 2001 1 - Malignant melanoma -
Fathallah-Shaykh et al. 1996 1 Primary Leptomeningeal
melanoma
-
Eaves et al. 1995 1 Primary Melanoma without
diffuse leptomeningeal
involvement
A variant of neurocutaneous melanosis
Rubino et al. 1993 1 Primary Melanoma -
Drake et al. 1993 8 Primary Malignant melanoma
of the leptomeninges
-
Singhal et al. 1991 1 Primary Melanoma -
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Table 2 Review of the English literature of CNS melanocytic lesions (Continued)
Fish et al. 1990 1 Primary Melanoma -
Salisbury et al. 1989 1 Primary Malignant melanoma In association with a giant congenital
melanocytic naevus of ‘bathing trunk’ distribution
Macfarlane et al. 1989 1 Primary Malignant melanoma
of the dura mater
-
Iglesias-Rozas et al. 1989 1 - Disseminated
melanomatosis of the
CNS and other organs
-
Larson et al. 1987 5 Primary Melanoma -
Tamura et al. 1981 1 Primary Leptomeningeal
malignant melanoma
Originated from the basal aspect of the brain.
The tumor showed not only spinal meningeal
dissemination but also infiltration into the
petrous bone and along the trigeminal nerve till
it reached the submucosal tissue of epipharynx.
Pasquier et al. 1978 1 primary Melanoma With multiple metastases in the liver
Hayward 1976 27 20 Metastatic, 6 Primary Malignant melanoma -






Enriquez et al. 1973 1 Primary Malignant melanoma Pineal involvement in a patient with nevus of ota
and multiple pigmented skin nevi.
Bergdahl et al. 1972 10 Primary Malignant melanoma -
CNS, central nervous system, the involved cases are all of the CNS, either intracranial or intraspinal; Nb, number of reported cases. aSome cases have no clear
evidence to be defined as primary or metastatic tumor.
Table 3 Review of the literature of CNS amelanotic melanoma
Author Year Nb Primary/metastatica Diagnosis Otherb
Schulz et al. [6] 2012 1 Primary Malignant amelanotic melanomas (in German)
Combined multiple intracranial and intraspinal
primary malignant amelanotic melanomas
Cemil et al. [7] 2008 1 Metastatic Amelanotic melanoma -
Karakis et al. [8] 2007 1 Metastatic Amelanotic melanoma -
Jacob et al. [9] 2006 1 - Amelanotic melanoma? -
Li et al. [10] 2004 1 - Amelanotic melanoma? (in Chinese)
Ogawa et al. [11] 2003 1 Metastatic Amelanotic melanoma -
Shields et al. [12] 2002 1 Metastatic Amelanotic melanoma -
Isiklar et al. [13] 1995 16 Metastatic Amelanotic melanoma -
Schadendorf et al. [14] 1993 1 - Amelanotic malignant melanoma -
Takahashi et al. [15] 1990 1 Metastatic Amelanotic melanoma (in Japanase)
Krüger et al. [16] 1987 1 Metastatic Amelanotic melanoma Associated with a congenital nevus of Ota
Sunada et al. [17] 1986 1 Unknown origin Amelanotic melanoma (in Japanase)
Out of review of primary uveal melanoma
2365 patients
Wagner et al. [18] 1981 1 - Amelanotic melanoma Amelanotic melanoma of the lung and brain
Schuknecht et al. [5] 1990 2 Primary Meningeal amelanotic
malignant melanoma
-
CNS, central nervous system, the involved cases are all of the CNS, either intracranial or intraspinal; Nb, number of reported cases. aSome cases have no clear
evidence to be defined as primary or metastatic tumor; bliterature in languages other than English is noted.
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earlier are not included because of the controversial diag-
nosis criterion before the 2007 WHO classification which
are widely adopted. The location involves all the CNS, from
supratentorial to intraspinal region. Due to the unspecific
resemblance, there were only few cases which were diag-
nosed before surgery, and the differentiations were quite
variable. The most common differentiations are tumors of
the meninges, which belong to the same group of the
melanocytic lesions, such as meningioma and the mes-
enchymal tumors. The hematopoietic neoplasms, cav-
ernous hemangioma, and even the cystic lesions are also
involved especially when there are hemorrhage, cystic
changes, or necrosis, and so on. One of them was sus-
pected as amelanotic melanoma. Our case is the second
one with definite diagnosis of amelanotic melanoma.
The clinical characteristics of amelanotic melanoma are
similar to other melanocytic lesions, with the neuroim-
aging performance as the major difference. Also, during
the operation, the amelanotic melanoma appears more
pale white, and the microscopic examination reviews
the lacking of melanin. As the overall examinations
were all negative, the primary intracranial amelanotic mel-
anoma was confirmed.
The prognosis of amelanotic melanoma is not quite
different from other CNS melanoma. Melanocytoma
lacks anaplastic features, but a few undergo local recur-
rences. Intermediate grade melanocytic tumors typically
invade the CNS. A rare example of malignant transform-
ation of a melanocytoma has been reported. Malignant
melanoma is highly aggressive and radioresistant, has
poor prognosis, and prone to metastasize. The prognosis
of diffuse melanosis is poor even in the absence of histo-
logic malignancy. The prognosis of the primary CNS
melanocytic lesions appears to be better than metastatic
examples. For our case of primary intracranial amelano-
tic melanoma, total resection was achieved as well as
excessive removal of invaded cranial bone and adjacent
meninges. The experience of postoperative adjuvant
therapy is quite poor. We adopted the radiotherapy and
chemotherapy regimen of concomitant stereotactic radio-
surgery + ipilimumab, referring to the NCCN guidelines
for melanoma (2.2015 version). With adjuvant radiother-
apy and chemotherapy, the patient is tumor-free 5 months
later and is still under follow-up.
Conclusions
CNS amelanotic melanoma is quite rare. The clinical
characteristics are similar to other melanocytic lesions,
with the neuroimaging performance as the major differ-
ence. The prognosis of amelanotic melanoma is not quite
different from other CNS melanoma and appears to be
better than the metastatic cases, particularly if localized
and complete resection is possible.Consent
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